Quarterly report pursuant to Section 13 or 15(d)

Restatement (Details 1)

v2.4.0.6
Restatement (Details 1) (USD $)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Revenues $ 1,006,262 $ 842,885 $ 3,028,866 $ 1,536,630      
Cost of revenues 307,061 311,717 1,007,288 570,605      
Gross Margin 699,201 531,168 2,021,578 966,025      
Operating Expenses              
General & administrative 637,113 961,136 2,354,369 2,152,977      
Sales & marketing expense 406,815 240,722 1,135,934 514,185      
Engineering, research, & development expense 155,365 174,802 448,446 499,120      
Total Operating Expenses 1,329,872 1,568,443 4,370,711 3,484,842      
Loss From Operations (630,671) (1,037,275) (2,349,133) (2,518,817)      
Other Income/(Expense)              
Interest expense (1,781,125) (133,055) (3,019,625) (376,548)      
Change in fair market value of derivative liabilities 213,089 (401,710) 407,079 (986,216)      
Total Other Income/(Expense) (1,725,727) (534,765) (2,691,050) (1,362,764)      
Income tax benefit/(expense)    (1,600)    (1,562)      
Net Loss (2,356,398) (1,573,640) (5,040,183) (3,883,143) (16,312,989) (1,229,583) (1,402,627)
Net Loss Per Share - Basic and Diluted $ (0.10) $ (0.07) $ (0.22) $ (0.19)      
Weighted average number of shares during the period - basic and diluted 23,215,481 22,048,802 23,019,643 20,381,533      
As Filed [Member]
              
Revenues   842,885   1,536,630      
Cost of revenues   311,717   570,605      
Gross Margin   531,168   966,025      
Operating Expenses              
General & administrative   523,513   1,448,955      
Sales & marketing expense   245,810   497,936      
Engineering, research, & development expense   156,851   445,267      
Depreciation & amortization   191,783   318,560      
Total Operating Expenses   1,117,957   2,710,718      
Loss From Operations   (586,789)   (1,744,693)      
Other Income/(Expense)              
Interest expense   (133,055)   (376,548)      
Change in fair market value of derivative liabilities   (54,134)   152,822      
Total Other Income/(Expense)   (187,189)   (223,726)      
Loss before income taxes   (773,978)   (1,968,419)      
Income tax benefit/(expense)   (1,600)   (1,562)      
Net Loss   (775,578)   (1,969,981)      
Net Loss Per Share - Basic and Diluted   $ 0   $ (0.1)      
Weighted average number of shares during the period - basic and diluted   22,048,802   20,381,533      
AdjustmentsMember
              
Revenues                
Cost of revenues                
Gross Margin                
Operating Expenses              
General & administrative   437,623   704,022      
Sales & marketing expense   (5,088)   16,249      
Engineering, research, & development expense   17,951   53,853      
Depreciation & amortization                
Total Operating Expenses   450,486   774,124      
Loss From Operations   (450,486)   (774,124)      
Other Income/(Expense)              
Interest expense                
Change in fair market value of derivative liabilities   (347,576)   (1,139,038)      
Total Other Income/(Expense)   (347,576)   (1,139,038)      
Loss before income taxes   (798,062)   (1,913,162)      
Income tax benefit/(expense)                
Net Loss   (798,062)   (1,913,162)      
Net Loss Per Share - Basic and Diluted   $ 0   $ (0.09)      
Weighted average number of shares during the period - basic and diluted   22,048,802   20,381,533      
RestatedMember
              
Revenues   842,885   1,536,630      
Cost of revenues   311,717   570,605      
Gross Margin   531,168   966,025      
Operating Expenses              
General & administrative   961,136   2,152,977      
Sales & marketing expense   240,722   514,185      
Engineering, research, & development expense   174,802   499,120      
Depreciation & amortization   191,783   318,560      
Total Operating Expenses   1,568,443   3,484,842      
Loss From Operations   (1,037,275)   (2,518,817)      
Other Income/(Expense)              
Interest expense   (133,055)   (376,548)      
Change in fair market value of derivative liabilities   (401,710)   (986,216)      
Total Other Income/(Expense)   (534,765)   (1,362,764)      
Loss before income taxes   (1,572,040)   (3,881,581)      
Income tax benefit/(expense)   (1,600)   (1,562)      
Net Loss   $ (1,573,640)   $ (3,883,143)      
Net Loss Per Share - Basic and Diluted   $ 0   $ (0.19)      
Weighted average number of shares during the period - basic and diluted   22,048,802   20,381,533